2017
DOI: 10.1253/circj.cj-17-0124
|View full text |Cite
|
Sign up to set email alerts
|

Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
31
0
3

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(37 citation statements)
references
References 37 publications
3
31
0
3
Order By: Relevance
“…There are studies demonstrating that high CRP levels and hypoalbuminaemia both independently and synergistically increased the risk of MACE in the long term in patients undergoing percutaneous coronary intervention . The present study is the first to assess their impact in an acute setting and basically demonstrated similar deleterious effects of the two biomarkers.…”
Section: Discussionsupporting
confidence: 62%
“…There are studies demonstrating that high CRP levels and hypoalbuminaemia both independently and synergistically increased the risk of MACE in the long term in patients undergoing percutaneous coronary intervention . The present study is the first to assess their impact in an acute setting and basically demonstrated similar deleterious effects of the two biomarkers.…”
Section: Discussionsupporting
confidence: 62%
“…On the other hand, other interventional studies failed to show a significant correlation between CRP levels and recurrent events or restenosis after elective or emergent PCI (Almagor et al, 2003;Bafadhel, Kishk, & Yousef, 2013;Youssef et al, 2012). Data from recent studies have shown a significant reduction in hs-CRP levels after statin treatment (Badran et al, 2013;Ding, Hu, Wu, & Tomlinson, 2015), which were inversely correlated with the rate of disease progression in patients with CAD (Almagor et al, 2003;Nakou et al, 2008;Wada et al, 2017).…”
Section: Angiographymentioning
confidence: 99%
“…The CAR is widely used to assess the prognosis of patients with cancers and atherosclerosis. An increased CAR indicates a poor clinical prognosis in patients undergoing percutaneous coronary intervention [31]. Recent studies showed that the CAR was predictive of disease progression and mortality in patients with gastric cancer, pancreatic cancer and non-small-cell lung cancer [13,22,32,33].…”
Section: Discussionmentioning
confidence: 99%